These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 32430065)

  • 1. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy.
    He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C
    Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term engraftment of myogenic progenitors from adipose-derived stem cells and muscle regeneration in dystrophic mice.
    Zhang Y; Zhu Y; Li Y; Cao J; Zhang H; Chen M; Wang L; Zhang C
    Hum Mol Genet; 2015 Nov; 24(21):6029-40. PubMed ID: 26264578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR).
    Elhussieny A; Nogami K; Sakai-Takemura F; Maruyama Y; Takemura N; Soliman WT; Takeda S; Miyagoe-Suzuki Y
    Stem Cell Res Ther; 2021 Oct; 12(1):532. PubMed ID: 34627382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
    Lala-Tabbert N; Fu D; Wiper-Bergeron N
    Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation of Dystrophin Expressing Chimeric Human Cells of Myoblast/Mesenchymal Stem Cell Origin Improves Function in Duchenne Muscular Dystrophy Model.
    Siemionow M; Szilagyi E; Cwykiel J; Domaszewska-Szostek A; Heydemann A; Garcia-Martinez J; Siemionow K
    Stem Cells Dev; 2021 Feb; 30(4):190-202. PubMed ID: 33349121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation.
    Goudenege S; Lebel C; Huot NB; Dufour C; Fujii I; Gekas J; Rousseau J; Tremblay JP
    Mol Ther; 2012 Nov; 20(11):2153-67. PubMed ID: 22990676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pluripotent stem cell-induced skeletal muscle progenitor cells with givinostat promote myoangiogenesis and restore dystrophin in injured Duchenne dystrophic muscle.
    Xuan W; Khan M; Ashraf M
    Stem Cell Res Ther; 2021 Feb; 12(1):131. PubMed ID: 33579366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle engraftment of myogenic progenitor cells following intraarterial transplantation.
    Bachrach E; Perez AL; Choi YH; Illigens BM; Jun SJ; del Nido P; McGowan FX; Li S; Flint A; Chamberlain J; Kunkel LM
    Muscle Nerve; 2006 Jul; 34(1):44-52. PubMed ID: 16634061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas9 editing of directly reprogrammed myogenic progenitors restores dystrophin expression in a mouse model of muscular dystrophy.
    Domenig SA; Bundschuh N; Lenardič A; Ghosh A; Kim I; Qabrati X; D'Hulst G; Bar-Nur O
    Stem Cell Reports; 2022 Feb; 17(2):321-336. PubMed ID: 34995499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy.
    Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS
    Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling Duchenne Muscular Dystrophy Cardiomyopathy with Patients' Induced Pluripotent Stem-Cell-Derived Cardiomyocytes.
    Eisen B; Binah O
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal skeletal muscle progenitors have regenerative capacity after intramuscular engraftment in dystrophin deficient mice.
    Sakai H; Sato T; Sakurai H; Yamamoto T; Hanaoka K; Montarras D; Sehara-Fujisawa A
    PLoS One; 2013; 8(5):e63016. PubMed ID: 23671652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy.
    Kimura E; Han JJ; Li S; Fall B; Ra J; Haraguchi M; Tapscott SJ; Chamberlain JS
    Hum Mol Genet; 2008 Aug; 17(16):2507-17. PubMed ID: 18511457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional myogenic engraftment from mouse iPS cells.
    Darabi R; Pan W; Bosnakovski D; Baik J; Kyba M; Perlingeiro RC
    Stem Cell Rev Rep; 2011 Nov; 7(4):948-57. PubMed ID: 21461712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duchenne muscular dystrophy hiPSC-derived myoblast drug screen identifies compounds that ameliorate disease in mdx mice.
    Sun C; Choi IY; Rovira Gonzalez YI; Andersen P; Talbot CC; Iyer SR; Lovering RM; Wagner KR; Lee G
    JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32343677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premyogenic progenitors derived from human pluripotent stem cells expand in floating culture and differentiate into transplantable myogenic progenitors.
    Sakai-Takemura F; Narita A; Masuda S; Wakamatsu T; Watanabe N; Nishiyama T; Nogami K; Blanc M; Takeda S; Miyagoe-Suzuki Y
    Sci Rep; 2018 Apr; 8(1):6555. PubMed ID: 29700358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of Functional Full-Length Dystrophin After Intramuscular Transplantation of Foamy Virus-Transduced Myoblasts.
    Meng J; Sweeney NP; Doreste B; Muntoni F; McClure M; Morgan J
    Hum Gene Ther; 2020 Feb; 31(3-4):241-252. PubMed ID: 31801386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells.
    Filareto A; Parker S; Darabi R; Borges L; Iacovino M; Schaaf T; Mayerhofer T; Chamberlain JS; Ervasti JM; McIvor RS; Kyba M; Perlingeiro RC
    Nat Commun; 2013; 4():1549. PubMed ID: 23462992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extraocular muscle satellite cells are high performance myo-engines retaining efficient regenerative capacity in dystrophin deficiency.
    Stuelsatz P; Shearer A; Li Y; Muir LA; Ieronimakis N; Shen QW; Kirillova I; Yablonka-Reuveni Z
    Dev Biol; 2015 Jan; 397(1):31-44. PubMed ID: 25236433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy.
    Siemionow M; Cwykiel J; Heydemann A; Garcia J; Marchese E; Siemionow K; Szilagyi E
    Stem Cell Rev Rep; 2018 Jun; 14(3):370-384. PubMed ID: 29546607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.